Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3.

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3. J Clin Oncol. 2016 Apr 20; 34(12):1402-18.

View in: PubMed

subject areas

Antineoplastic Agents
Biomarkers, Tumor
Biopsy
Clinical Trials as Topic
Consensus
Diagnostic Imaging
Disease Progression
Disease-Free Survival
Drug Approval
Drug Resistance, Neoplasm
Genetic Predisposition to Disease
Humans
Kallikreins
Male
Molecular Diagnostic Techniques
Phenotype
Predictive Value of Tests
Prostate-Specific Antigen
Prostatic Neoplasms, Castration-Resistant
Research Design
Risk Assessment
Risk Factors
Surveys and Questionnaires
Time Factors
Treatment Outcome

authors with profiles

Walter M. Stadler